The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glycan modifications can be dynamically regulated and serve as fundamental mechanisms for modulating cell behavior, including affinity of a glycoprotein or glycolipid to a host of carbohydrate binding proteins (Arthur et al., 2015a; Bochner and Zimmermann, 2015; Johannes et al., 2018; Rabinovich et al., 2012).”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Bochner and Zimmermann, 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Siglec-mediated regulation of immune cell function in disease
Macauley, M. S., Crocker, P. R., & Paulson, J. C. (2014) · Nature Reviews Immunology · doi:10.1038/nri3737 · Cited by 1,122
A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800
CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses
Chen, G.-Y., Tang, J., Zheng, P., & Liu, Y. (2009) · Science · doi:10.1126/science.1168988 · Cited by 786 · cited 1×
“Physiologic inhibitory signaling through Siglec-10 and Siglec-G occurs as a result of engagement of sialic acid residues on CD24, a glycosylphosphatidylinositol–linked protein on the surfaces of B cells and granulocytes.(90) In addition to CD24 as a ligand, some antigen-activated humanT cells suppress other T cells in…”
Human dectin-1 deficiency and mucocutaneous fungal infections
Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901053 · Cited by 752
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
Paszek, M. J., DuFort, C. C., Rossier, O., Bainer, R., Mouw, J. K., Godula, K., Hudak, J. E., Lakins, J. N., Wijekoon, A. C., Cassereau, L., et al. (2014) · Nature · doi:10.1038/nature13535 · Cited by 699
Carlin, A. F., Uchiyama, S., Chang, Y.-C., Lewis, A. L., Nizet, V., & Varki, A. (2009) · Blood · doi:10.1182/blood-2008-11-187302 · Cited by 401
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Research works printed but not linked: 101
- Lepenies, 2013, Targeting C-type lectin receptors with multivalent carbohydrate ligands, Adv Drug Deliv Rev, 65, 1271, 10.1016/j.addr.2013.05.007 · DOI · Paper page
- Powlesland, 2010, Engineered carbohydrate-recognition domains for glycoproteomic analysis of cell surface glycosylation and ligands for glycan-binding receptors, Methods Enzymol, 480, 165, 10.1016/S0076-6879(10)80009-6 · doi:10.1016/s0076-6879(10)80009-6
- Rabinovich, 2012, Glycobiology of immune responses, Ann N Y Acad Sci, 1253, 1, 10.1111/j.1749-6632.2012.06492.x · DOI · Paper page
- Stowell, 2014, Microbial glycan microarrays define key features of host-microbial interactions, Nat Chem Biol, 10, 470, 10.1038/nchembio.1525 · DOI · Paper page
- Varki, 2012, Multifarious roles of sialic acids in immunity, Ann N Y Acad Sci, 1253, 16, 10.1111/j.1749-6632.2012.06517.x · DOI · Paper page
- Varki, 2007, Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins, Nature, 446, 1023, 10.1038/nature05816 · DOI · Paper page
- Varki, 2006, Siglecs—the major sub-family of I-type lectins, Glycobiology, 16, 1R, 10.1093/glycob/cwj008 · DOI · Paper page
- Crocker, 2007, Siglecs and their roles in the immune system, Nat Rev Immunol, 7, 255, 10.1038/nri2056 · DOI · Paper page
- von Gunten, 2008, Basic and clinical immunology of Siglecs, Ann N Y Acad Sci, 1143, 61, 10.1196/annals.1443.011 · DOI · Paper page
- Pillai, 2012, Siglecs and immune regulation, Annu Rev Immunol, 30, 357, 10.1146/annurev-immunol-020711-075018 · DOI · Paper page
- Paulson, 2012, Siglecs as sensors of self in innate and adaptive immune responses, Ann N Y Acad Sci, 1253, 37, 10.1111/j.1749-6632.2011.06362.x · DOI
- Crocker, 2012, CD33-related siglecs as potential modulators of inflammatory responses, Ann N Y Acad Sci, 1253, 102, 10.1111/j.1749-6632.2011.06449.x · DOI
- Schnaar, 2015, Glycans and glycan binding proteins in immune regulation: a concise introduction to glycobiology for the allergist, J Allergy Clin Immunol, 135, 609, 10.1016/j.jaci.2014.10.057 · DOI
- Bochner, 2005, Glycan array screening reveals a candidate ligand for Siglec-8, J Biol Chem, 280, 4307, 10.1074/jbc.M412378200 · DOI · Paper page
- Kiwamoto, 2014, Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation, J Allergy Clin Immunol, 133, 240, 10.1016/j.jaci.2013.05.018 · DOI
- Tateno, 2005, Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6′-sulfo-sialyl Lewis X as a preferred glycan ligand, Glycobiology, 15, 1125, 10.1093/glycob/cwi097 · DOI · Paper page
- Bochner, 2009, Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors, Clin Exp Allergy, 39, 317, 10.1111/j.1365-2222.2008.03173.x · DOI · Paper page
- Zhang, 2004, The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils, Eur J Immunol, 34, 1175, 10.1002/eji.200324723 · DOI · Paper page
- Kano, 2013, Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation, J Allergy Clin Immunol, 132, 437, 10.1016/j.jaci.2013.03.024 · DOI
- Nutku, 2003, Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis, Blood, 101, 5014, 10.1182/blood-2002-10-3058 · DOI · Paper page
- Nutku, 2005, Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury, Biochem Biophys Res Commun, 336, 918, 10.1016/j.bbrc.2005.08.202 · DOI
- Nutku-Bilir, 2008, Interleukin-5 priming of human eosinophils alters Siglec-8 mediated apoptosis pathways, Am J Respir Cell Mol Biol, 38, 121, 10.1165/rcmb.2007-0154OC · DOI
- von Gunten, 2005, Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment, Blood, 106, 1423, 10.1182/blood-2004-10-4112 · DOI · Paper page
- Rashmi, 2009, Siglec-9 and SHP-1 are differentially expressed in neonatal and adult neutrophils, Pediatr Res, 66, 266, 10.1203/PDR.0b013e3181b1bc19 · DOI
- McMillan, 2014, Siglec-E promotes β2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung, J Biol Chem, 289, 20370, 10.1074/jbc.M114.574624 · DOI
- Yokoi, 2008, Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by Siglec-8 engagement, J Allergy Clin Immunol, 121, 499, 10.1016/j.jaci.2007.10.004 · DOI
- Mao, 2013, Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen, PLoS One, 8, e68143, 10.1371/journal.pone.0068143 · DOI
- Avril, 2004, The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells, J Immunol, 173, 6841, 10.4049/jimmunol.173.11.6841 · DOI · Paper page
- Varchetta, 2012, Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes, PLoS One, 7, e45821, 10.1371/journal.pone.0045821 · DOI
- Kiwamoto, 2012, Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions, Pharmacol Ther, 135, 327, 10.1016/j.pharmthera.2012.06.005 · DOI · Paper page
- von Gunten, 2009, Different patterns of Siglec-9-mediated neutrophil death responses in septic shock, Shock, 32, 386, 10.1097/SHK.0b013e3181a1bc98 · doi:10.1097/shk.0b013e3181a1bc98
- Hudson, 2009, Eosinophil-selective binding and pro-apoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6′-sulfated sialyl Lewis X, J Pharmacol Exp Ther, 330, 608, 10.1124/jpet.109.152439 · DOI
- Guo, 2011, Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs, Am J Respir Cell Mol Biol, 44, 238, 10.1165/rcmb.2010-0007OC · DOI
- Patnode, 2013, Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue, J Biol Chem, 288, 26533, 10.1074/jbc.M113.485409 · DOI
- Kiwamoto, 2014, Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis, J Allergy Clin Immunol, 10.1016/j.jaci.2013.12.579 · doi:10.1016/j.jaci.2013.12.579
- Zarbock, 2011, Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow, Blood, 118, 6743, 10.1182/blood-2011-07-343566 · DOI · Paper page
- McEver, 2010, Rolling cell adhesion, Annu Rev Cell Dev Biol, 26, 363, 10.1146/annurev.cellbio.042308.113238 · DOI · Paper page
- Bochner, 2000, Road signs guiding leukocytes along the inflammation superhighway, J Allergy Clin Immunol, 106, 817, 10.1067/mai.2000.110813 · DOI
- Sandrin, 1995, Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis, Nat Med, 1, 1261, 10.1038/nm1295-1261 · DOI · Paper page
- Steinke, 2015, The alpha gal story: lessons learned from connecting the dots, J Allergy Clin Immunol, 135, 589, 10.1016/j.jaci.2014.12.1947 · DOI · Paper page
- Oliveira, 2010, Laboratory evaluation of primary immunodeficiencies, J Allergy Clin Immunol, 125, S297, 10.1016/j.jaci.2009.08.043 · DOI
- von Gunten, 2009, Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass, J Allergy Clin Immunol, 123, 1268, 10.1016/j.jaci.2009.03.013 · DOI
- Dalziel, 2014, Emerging principles for the therapeutic exploitation of glycosylation, Science, 343, 1235681, 10.1126/science.1235681 · DOI · Paper page
- Prasanphanich, 2014, Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite, Glycobiology, 24, 619, 10.1093/glycob/cwu027 · DOI
- Scanlan, 2007, Exploiting the defensive sugars of HIV-1 for drug and vaccine design, Nature, 446, 1038, 10.1038/nature05818 · DOI · Paper page
- Webster, 2014, Continuing challenges in influenza, Ann N Y Acad Sci, 1323, 115, 10.1111/nyas.12462 · DOI · Paper page
- Rempel, 2008, Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity, PLoS One, 3, e1967, 10.1371/journal.pone.0001967 · DOI · Paper page
- van der Kuyl, 2007, Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression, PLoS One, 2, e257, 10.1371/journal.pone.0000257 · DOI
- Puryear, 2012, HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells, Proc Natl Acad Sci U S A, 109, 7475, 10.1073/pnas.1201104109 · DOI
- Kardava, 2011, Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors, J Clin Invest, 121, 2614, 10.1172/JCI45685 · DOI
- Chen, 2013, Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation, Cell, 152, 467, 10.1016/j.cell.2013.01.011 · DOI · Paper page
- Varki, 2010, Colloquium paper: uniquely human evolution of sialic acid genetics and biology, Proc Natl Acad Sci U S A, 107, 8939, 10.1073/pnas.0914634107 · DOI · Paper page
- Chang, 2014, The interplay between Siglecs and sialylated pathogens, Glycobiology, 24, 818, 10.1093/glycob/cwu067 · DOI
- Angata, 2013, Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation, Cell Mol Life Sci, 70, 3199, 10.1007/s00018-013-1311-7 · DOI
- Ali, 2014, Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus, J Exp Med, 211, 1231, 10.1084/jem.20131853 · DOI · Paper page
- Chen, 2014, Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1, Elife, 3, e04066, 10.7554/eLife.04066 · DOI
- Etzioni, 2000, Leukocyte adhesion deficiency II-from A to almost Z, Immunol Rev, 178, 138, 10.1034/j.1600-065X.2000.17805.x · DOI
- van de Vijver, 2012, Hematologically important mutations: leukocyte adhesion deficiency (first update), Blood Cells Mol Dis, 48, 53, 10.1016/j.bcmd.2011.10.004 · DOI · Paper page
- Arnold, 2007, The impact of glycosylation on the biological function and structure of human immunoglobulins, Annu Rev Immunol, 25, 21, 10.1146/annurev.immunol.25.022106.141702 · DOI · Paper page
- Schwab, 2013, Intravenous immunoglobulin therapy: how does IgG modulate the immune system?, Nat Rev Immunol, 13, 176, 10.1038/nri3401 · DOI · Paper page
- von Gunten, 2014, IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist, Nat Rev Immunol, 14, 349, 10.1038/nri3401-c1 · DOI
- Samuelsson, 2001, Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor, Science, 291, 484, 10.1126/science.291.5503.484 · DOI · Paper page
- Anthony, 2008, Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc Natl Acad Sci U S A, 105, 19571, 10.1073/pnas.0810163105 · DOI · Paper page
- Masuda, 2007, Enhanced binding affinity for FcγRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity, Mol Immunol, 44, 3122, 10.1016/j.molimm.2007.02.005 · DOI · Paper page
- Chung, 2014, Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies—impact of effector cells, J Immunol Methods, 407, 63, 10.1016/j.jim.2014.03.021 · DOI
- Kolbeck, 2010, MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function, J Allergy Clin Immunol, 125, 1344, 10.1016/j.jaci.2010.04.004 · DOI · Paper page
- Jandus, 2014, Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance, J Clin Invest, 124, 1810, 10.1172/JCI65899 · DOI · Paper page
- Hudak, 2014, Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion, Nat Chem Biol, 10, 69, 10.1038/nchembio.1388 · DOI · Paper page
- Kimura, 2013, MUC1 immunotherapy is here to stay, Expert Opin Biol Ther, 13, 35, 10.1517/14712598.2012.725719 · DOI
- Mizrahi, 2014, Siglec-7 is an inhibitory receptor on human mast cells and basophils, J Allergy Clin Immunol, 134, 230, 10.1016/j.jaci.2014.03.031 · DOI
- Zimmermann, 2008, Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils, Allergy, 63, 1156, 10.1111/j.1398-9995.2008.01709.x · DOI
- Song, 2009, Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling, J Immunol, 183, 5333, 10.4049/jimmunol.0801421 · DOI
- Rubinstein, 2011, Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis, J Pediatr Gastroenterol Nutr, 53, 409, 10.1097/MPG.0b013e3182182ff8 · DOI
- Song, 2009, Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model, Clin Immunol, 131, 157, 10.1016/j.clim.2008.11.009 · doi:10.1016/j.clim.2008.11.009
- Zhang, 2007, Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils, Blood, 109, 4280, 10.1182/blood-2006-08-039255 · DOI · Paper page
- Cho, 2010, Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13, Respir Res, 11, 154, 10.1186/1465-9921-11-154 · DOI
- Suzukawa, 2013, Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice, J Immunol, 190, 5939, 10.4049/jimmunol.1203455 · DOI
- Kiwamoto, 2013, The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation, Curr Opin Allergy Clin Immunol, 13, 106, 10.1097/ACI.0b013e32835b594a · DOI
- Muller, 2014, The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease, Nat Rev Rheumatol, 10, 422, 10.1038/nrrheum.2014.54 · DOI
- Hoffmann, 2007, Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population, Nat Immunol, 8, 695, 10.1038/ni1480 · DOI · Paper page
- Bokers, 2014, Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice, J Immunol, 192, 2994, 10.4049/jimmunol.1303367 · DOI
- Toubai, 2014, Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice, Blood, 123, 3512, 10.1182/blood-2013-12-545335 · DOI
- Jellusova, 2010, CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity, J Immunol, 184, 3618, 10.4049/jimmunol.0902711 · DOI
- Bandala-Sanchez, 2013, T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10, Nat Immunol, 14, 741, 10.1038/ni.2610 · DOI · Paper page
- Grader-Beck, 2011, Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease, Ann Rheum Dis, 70, 2218, 10.1136/ard.2011.153130 · DOI
- Dotan, 2006, Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease, Gastroenterology, 131, 366, 10.1053/j.gastro.2006.04.030 · DOI · Paper page
- Dotan, 2006, Anti-glycan antibodies as biomarkers for diagnosis and prognosis, Lupus, 15, 442, 10.1191/0961203306lu2331oa · DOI
- Rillahan, 2012, Click and pick: identification of sialoside analogues for siglec-based cell targeting, Angew Chem Int Ed Engl, 51, 11014, 10.1002/anie.201205831 · DOI
- Nycholat, 2012, In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages, J Am Chem Soc, 134, 15696, 10.1021/ja307501e · DOI
- Rillahan, 2014, Disubstituted sialic acid ligands targeting Siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas, Chem Sci, 5, 2398, 10.1039/c4sc00451e · DOI
- O'Reilly, 2009, Siglecs as targets for therapy in immune-cell-mediated disease, Trends Pharmacol Sci, 30, 240, 10.1016/j.tips.2009.02.005 · DOI · Paper page
- Kawasaki, 2013, Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation, Proc Natl Acad Sci U S A, 110, 7826, 10.1073/pnas.1219888110 · DOI
- Kawasaki, 2014, Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation, J Immunol, 193, 1560, 10.4049/jimmunol.1303278 · DOI
- Duong, 2010, Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo, J Exp Med, 207, 173, 10.1084/jem.20091873 · DOI · Paper page
- Macauley, 2013, Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis, J Clin Invest, 123, 3074, 10.1172/JCI69187 · DOI · Paper page
- Pfrengle, 2013, Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22, J Immunol, 191, 1724, 10.4049/jimmunol.1300921 · DOI
- von Gunten, 2006, Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations, Blood, 108, 4255, 10.1182/blood-2006-05-021568 · DOI
- von Gunten, 2007, Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies, J Allergy Clin Immunol, 119, 1005, 10.1016/j.jaci.2007.01.023 · DOI
- Collin, 2008, IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions, Proc Natl Acad Sci U S A, 105, 4265, 10.1073/pnas.0711271105 · DOI
- Lood, 2012, IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?, Arthritis Rheum, 64, 2698, 10.1002/art.34454 · DOI
- Nandakumar, 2013, Dominant suppression of inflammation by glycan-hydrolyzed IgG, Proc Natl Acad Sci U S A, 110, 10252, 10.1073/pnas.1301480110 · DOI
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Glycosylation: mechanisms, biological functions and clinical implications
He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 499
Sialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
Lübbers, J., Rodríguez, E., & van Kooyk, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02807 · Cited by 260
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Shivatare, S. S., Shivatare, V. S., & Wong, C.-H. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01032 · Cited by 257
Metadata
- Authors
- Bochner, B. S., & Zimmermann, N.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 135
- Issue
- 3
- Pages
- 598-608
- ISSN
- 0091-6749
- Cited by
- 113
- References
- 13
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Institutes of Health (R01 AI072265, P01 HL107151)
- Johns Hopkins University (SRA 130701, R21 AI103853)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation. https://app.cochat.ai/papers/10.1016/j.jaci.2014.11.031
- The paper
- Bochner, B. S., & Zimmermann, N. (2015). Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2014.11.031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.